Literature DB >> 24585643

Pulmonary thromboembolism in lung surgery: use of unfractionated heparin.

Junichi Yoshida1, Masaaki Inoue, Koichi Furugaki, Mayumi Oyama, Keigo Oozono.   

Abstract

BACKGROUND: While thoracic surgeons occasionally encounter pulmonary thromboembolism, the use of unfractionated heparin may cause adverse effects.
METHODS: We assessed a series of 323 consecutive pulmonary operations performed during 4 years from 2008 to 2011. All patients were given elastic stockings and intermittent pneumatic compression. During the first 2 years (2008-2009), none of the 169 patients received unfractionated heparin. In the second 2-year period (2010-2011), 135/154 patients received subcutaneous unfractionated heparin, either 5000 units (n = 37) or 2500 units (n = 93) twice daily for 3 days, or continuous intravenous unfractionated heparin (n = 5). The epidural catheters were withdrawn 6 h or more after unfractionated heparin use. Among patients without postoperative unfractionated heparin, 8 (42.1%) had a bleeding risk and 5 (26.3%) had limited operative time.
RESULTS: One (0.6%) patient developed pulmonary thromboembolism during 2008-2009, but none had this complication during 2010-2011. The adverse outcome of intrathoracic bleeding occurred in one (2.7%) of the patients given 5000 units of unfractionated heparin, but no epidural hematomas occurred in these patients.
CONCLUSION: Patients undergoing thoracic surgery at low risk of bleeding may receive unfractionated heparin to prevent pulmonary thromboembolism while avoiding epidural complications.

Entities:  

Keywords:  Anesthesia epidural; Heparin; Intermittent pneumatic compression devices; Pulmonary embolism; Pulmonary surgical procedures; Stockings; compression

Mesh:

Substances:

Year:  2013        PMID: 24585643     DOI: 10.1177/0218492313475672

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  2 in total

Review 1.  Postoperative Acute Pulmonary Embolism Following Pulmonary Resections.

Authors:  Felix Samuel Shonyela; Shuangqiang Yang; Bo Liu; Jia Jiao
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-09-09       Impact factor: 1.520

2.  Effect of low molecular weight heparin on venous thromboembolism disease in thoracotomy patients with cancer.

Authors:  Jun Dong; Jia Wang; Yuan Feng; Li-Ping Qi; Hua Fang; Guo-Dong Wang; Zhou-Qiao Wu; Hong-Zhi Wang; Yue Yang; Qing Li
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.